7554 Theis and Ritter
Macromolecules, Vol. 36, No. 20, 2003
Mesoion ic 5-Bu tyl-1-(4-eth oxyp h en yl)-2-[4-(isop r op e-
n ylca r bon yloxy)b u t ylt h io]-6-oxo-3-p h en yl-1,6-d ih yd r o-
p yr im id in -3-iu m -4-ola te (14). 1.0 g (2.42 mmol) of S-4-
(is op r op en ylca r bon yloxy)bu t yl-N -4-et h oxyp h en yl-N ′-
phenylisothiourea and 1.0 g (4.84 mmol) of DCC were dissolved
under stirring in 5 mL of dry dichloromethane. Then 0.39 g
(2.42 mmol) of butylmalonic acid was added batchwise for a
period of 10 min under exclusion of moisture. After 50 min of
additional stirring, the precipitated urea was filtered off and
washed with a small amount of dichloromethane. The com-
bined dichloromethane fractions were concentrated in a vacuum,
and 250 mL of petroleum ether was added under stirring. After
15 min, the petroleum ether was decanted, and the yellow
residue was dried in a vacuum. For further purification, the
crude product was chromatographed over silica gel (ethyl
acetate/petroleum ether 7/3 v/v); yield 0.6 g (47%). Yellow
added to 55 mL of ethyl acetate and boiled under reflux for 24
h. The reaction mixture was cooled to room temperature, the
precipitate was filtered off, and the ethyl acetate was removed
by distillation in a vacuum. For purification, the crude product
was dissolved in 6 mL of dichloromethane and precipitated in
70 mL of methanol. The product was filtered off, washed with
additional methanol, and dried in a vacuum; yield 3.2 g (68%).
Colorless crystals; 400 MHz 1H NMR (CDCl3): δ [ppm] ) 0.65
(s, 3 H, 30-H), 0.77-2.02 (m, 49 H, 3,8,9,10,16,17,20,21,22,-
23,24,26,27,29,31,32,33,34,35,36,37,38,39,40,41-H), 2.27 (t, 2
H, 11-H, J ) 7.3 Hz), 4.11 (t, 2 H, 7-H, J ) 6.6 Hz), 4.59 (m,
1 H, 15-H), 5.34 (m, 1 H, 25-H), 5.52 (s, 1 H, 1-H), 6.06 (s, 1
H, 1-H). 100 MHz 13C NMR (CDCl3): δ [ppm] ) 11.77 (C-30),
18.17 (C-3), 18.66 (C-35), 19.21 (C-21), 20.99 (C-26), 22.46/22.71
(C-40,41), 23.79 (C-37), 24.21 (C-33), 24.60 (C-9), 25.50 (C-10),
27.76 (C-16), 27.91 (C-39), 28.14 (C-32), 28.27 (C-8), 31.84 (C-
23), 31.89 (C-24), 34.41 (C-11), 35.71 (C-34), 36.13 (C-36), 36.51
(C-18), 36.95 (C-17), 38.10 (C-20), 39.46 (C-27), 39.71 (C-38),
42.26 (C-28), 50.02 (C-22), 56.14 (C-31), 56.65 (C-29), 64.35
(C-7), 73.71 (C-15), 122.50 (C-25), 124.98 (C-1), 136.42 (C-2),
1
highly viscous oil; 400 MHz H NMR (DMSO-d6): δ [ppm] )
0.85 (t, 3 H, 28-H, J ) 6.8 Hz), 1.16-1.44 (m, 11 H, 6,7,26,-
27,38-H), 1.83 (s, 3 H, 16-H), 2.17 (t, 2 H, 8-H, J ) 6.8 Hz),
2.25 (t, 2 H, 25-H, J ) 7.6 Hz), 3.89 (t, 2 H, 5-H, J ) 6.1 Hz),
4.02 (q, 2 H, 37-H, J ) 7.2 Hz), 5.65 (s, 1 H, 1-H), 5.94 (s, 1 H,
1-H), 7.00 (d, 2 H, 32,34-H, J ) 8.8 Hz), 7.38 (d, 2 H, 31,35-H,
J ) 8.8 Hz), 7.42-7.53 (m, 5 H, 19,20,21,22,23-H). 50 MHz
13C NMR (DMSO-d6): δ [ppm] ) 13.93 (C-28), 14.49 (C-38),
17.87 (C-16), 22.33/24.27/25.39/26.62/30.00/34.79 (C-6, C-7,
C-8, C-25, C-26, C-27), 63.39 (C-5), 64.21 (C-37), 94.60 (C-13),
114.22 (C-32,34), 125.51 (C-1), 128.69 (C-19,20,22,23), 128.88
(C-21), 129.79 (C-31,35), 130.49 (C-30), 135.81 (C-2), 138.22
(C-18), 158.61/159.09/159.25/160.06 (C-10, C-12, C-14, C-33),
166.32 (C-3). IR (KBr): λ-1 [cm-1] ) 3061 (ar C-H), 2954,
2929, 2869 (aliph C-H), 1716 (CdO), 1641 (mesoion CdO),
1594 (ar CdC); further signals at 1510, 1478, 1455, 1394, 1366,
1319, 1299, 1249, 1171, 1116, 1068, 1045, 758, 699. UV
(dichloromethane): λmax [nm] (log ꢀ) ) 266 (4.03), 375 (3.26).
MS (FD): m/z (%) ) 537 (100) [M+].
139.58 (C-19), 167.24 (C-4), 172.66 (C-12). IR (KBr): λ-1 [cm-1
]
) 2945, 2867 (C-H), 1733, 1723 (CdO); further signals at
1638, 1467, 1377, 1366, 1321, 1297, 1255, 1236, 1169, 1029,
1012, 940. DSC: ∆Cp (negative) ) 4 °C. Peak ) 35 °C. Peak
) 64 °C. MS (FD): m/z (%) ) 569 (2) [M+], 387 (10)
[cholesterol+], 369 (100) [cholesteryl+].
EA: C30H36N2O5S (536.70). Calcd: C, 67.14; H, 6.76; N, 5.22;
S, 5.97. Found: C, 66.35; H, 7.09; N, 5.33; S, 5.80.
EA: C37H60O4 (568.89). Calcd: C, 78.12; H, 10.63. Found:
C, 77.72; H, 10.34.
1-Br om h exa n oic Acid Ch olester yl Ester (17). 15.46 g
(40 mmol) of cholesterol, 8.25 g (40 mmol) of DCC, and 0.49 g
(4 mmol) of 4-(dimethylamino)pyridine were dissolved in 70
mL of dichloromethane. Then 7.8 g (40 mmol) of 1-bromohex-
anoic acid was added under stirring over a period of 20 min,
whereby the temperature was kept at room temperature by
use of a water bath. The solution was stirred for additional 2
h, and then the precipitated urea was filtered off and washed
Cop olym er of Meth yl Meth a cr yla te a n d Mesoion ic
5-Bu tyl-1-(4-eth oxyph en yl)-2-[4-(isopr open ylcar bon yloxy)-
bu t ylt h io]-6-oxo-3-p h en yl-1,6-d ih yd r op yr im id in -3-iu m -
4-ola te (21). 0.50 g (0.93 mmol) of mesoionic 5-butyl-1-(4-
ethoxyphenyl)-2-[4-(isopropenylcarbonyloxy)butylthio]-6-oxo-
3-phenyl-1,6-dihydropyrimidin-3-ium-4-olate, 0.37 g (3.72 mmol)
of methyl methacrylate, and 23.0 mg (0.14 mmol) of AIBN were
dissolved in 2 mL of absolute DMF. The mixture was degassed
by exposure to nitrogen bubbles for 30 min. Then the solution
was polymerized for 20 h at 60 °C, and the polymer was
precipitated in a mixture of 100 mL of methanol and 200 mL
of water. After drying in a vacuum, the polymer was purified
by dissolving in 5 mL of dichloromethane and reprecipitating
in 150 mL of diethyl ether. The product was dried in a vacuum
again; yield 0.6 g (69%). Yellow powder; 400 MHz 1H NMR
(CDCl3): δ [ppm] ) 0.46-2.10 (m, 1,6,7,16,25,26,27,28,38,39,-
44-H), 2.42 (m, 8-H), 3.55 (s, 43-H), 3.65-4.12 (m, 5,37-H),
6.32-7.59 (m, ar-H). IR (KBr): λ-1 [cm-1] ) 2987, 2950, 2871
(aliph C-H), 1730 (CdO), 1651 (mesoion. CdO); further
signals at 1510, 1479, 1453, 1365, 1248, 1192, 1151, 1064, 995,
973, 924, 852, 757, 701. UV (dichloromethane): λmax [nm] )
263, 380. DSC: Tg ) 104 °C. SEC (chloroform, universal cali-
bration by viscosity): Mn ) 27 000, Mw ) 280 000, PD ) 11.
EA for n:m ) 4:1. Calcd: C, 64.08; H, 7.31; N, 2.99; S, 3.42.
Found: C, 63.35; H, 7.29; N, 3.07; S, 3.89.
with
a small amount of dichloromethane. The combined
dichloromethane fractions were evaporated in a vacuum. The
dried crude product could be used without further purification;
yield 22.5 g (100%). Colorless crystals; mp 110-113 °C; 400
1
MHz H NMR (CDCl3): δ [ppm] ) 0.64 (s, 3 H, 25-H), 0.77-
2.02 (m, 46 H, 3,4,5,11,12,15,16,17,18,19,21,22,24,26,27,28,-
29,30,31,32,33,34,35,36-H), 2.27 (t, 2 H, 6-H, J ) 7.5 Hz), 3.38
(t, 2 H, 2-H, J ) 6.8 Hz), 4.58 (m, 1 H, 10-H), 5.34 (m, 1 H,
20-H).
IR (KBr): λ-1 [cm-1] ) 2946, 2886, 2867 (C-H), 1733 (Cd
O); further signals at 1652, 1456, 1436, 1384, 1373, 1365, 1323,
1255, 1229, 1187, 1172, 999.
5-(Ch olester olca r bon yl)p en tyl Meth a cr yla te (19). 4.7
g (8.33 mmol) of 1-bromohexanoic acid cholesteryl ester, 1.03
g (8.33 mmol) of potassium methacrylate, 20 mg of hydro-
quinone monopropyl ether, and 0.044 g (0.12 mmol) of tet-
rabutylammonium iodide as phase transfer catalyst were